Trade NeoGenomics - NEOus CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 11.79 |
| Open | 11.76 |
| 1-Year Change | -19.89% |
| Day's Range | 10.88 - 11.76 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 11.05 | -0.86 | -7.22% | 11.91 | 11.91 | 10.85 |
| Feb 20, 2025 | 11.79 | -0.64 | -5.15% | 12.43 | 12.48 | 11.78 |
| Feb 19, 2025 | 12.66 | 0.57 | 4.71% | 12.09 | 13.07 | 11.73 |
| Feb 18, 2025 | 12.35 | -0.10 | -0.80% | 12.45 | 13.20 | 10.64 |
| Feb 14, 2025 | 14.38 | 0.59 | 4.28% | 13.79 | 14.67 | 13.74 |
| Feb 13, 2025 | 13.84 | 0.29 | 2.14% | 13.55 | 13.94 | 13.50 |
| Feb 12, 2025 | 13.73 | 0.67 | 5.13% | 13.06 | 13.83 | 13.02 |
| Feb 11, 2025 | 13.42 | 0.14 | 1.05% | 13.28 | 13.63 | 13.28 |
| Feb 10, 2025 | 13.50 | 0.06 | 0.45% | 13.44 | 13.56 | 13.00 |
| Feb 7, 2025 | 13.39 | 0.03 | 0.22% | 13.36 | 13.46 | 12.99 |
| Feb 6, 2025 | 13.43 | -0.63 | -4.48% | 14.06 | 14.06 | 13.42 |
| Feb 5, 2025 | 14.03 | 0.18 | 1.30% | 13.85 | 14.22 | 13.79 |
| Feb 4, 2025 | 13.90 | 0.14 | 1.02% | 13.76 | 14.01 | 13.71 |
| Feb 3, 2025 | 13.83 | 0.01 | 0.07% | 13.82 | 14.12 | 13.71 |
| Jan 31, 2025 | 14.23 | -0.50 | -3.39% | 14.73 | 14.79 | 14.23 |
| Jan 30, 2025 | 14.74 | 0.18 | 1.24% | 14.56 | 15.18 | 14.56 |
| Jan 29, 2025 | 14.52 | -0.41 | -2.75% | 14.93 | 15.01 | 14.46 |
| Jan 28, 2025 | 15.14 | 0.38 | 2.57% | 14.76 | 15.26 | 14.76 |
| Jan 27, 2025 | 14.99 | 0.17 | 1.15% | 14.82 | 15.21 | 14.69 |
| Jan 24, 2025 | 14.81 | 0.35 | 2.42% | 14.46 | 14.95 | 14.29 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
NeoGenomics Company profile
About NeoGenomics, Inc.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. It offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. It operates testing laboratories in United States, Europe and Asia.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, NeoGenomics, Inc. revenues increased 9% to $484.3M. Net loss totaled $8.3M vs. income of $4.2M. Revenues reflect Clinical Services segment increase of 6% to $404.2M, Pharma Services segment increase of 29% to $80.2M. Net loss reflects General and administrative increase of 38% to $167.2M (expense), Sales and marketing increase of 31% to $62.6M (expense).
Equity composition
Common Stock $0.001 Par, 03/12, 100M auth., 43,236,498. issd. Insiders own approx. 46.49%.
| Industry: | Medical & Diagnostic Laboratories |
9490 Neogenomics Way
FORT MYERS
FLORIDA 33912
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com